{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T18:48:07Z","timestamp":1788029287002,"version":"build-2784847793"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1038\/s41582-023-00906-y","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T12:02:38Z","timestamp":1702987358000},"page":"36-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Huntington disease-like 2: insight into neurodegeneration from an African disease"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7157-0807","authenticated-orcid":false,"given":"Amanda","family":"Krause","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2831-6424","authenticated-orcid":false,"given":"David G.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Ferreira-Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1933-6308","authenticated-orcid":false,"given":"Fiona","family":"Baine-Savanhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan P.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell L.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"906_CR1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker, F. O. Huntington\u2019s disease. Lancet 369, 218\u2013228 (2007).","journal-title":"Lancet"},{"key":"906_CR2","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/mds.29121","volume":"37","author":"GL Franklin","year":"2022","unstructured":"Franklin, G. L., Teive, H. A. G., Meira, A. T., Nepomuceno, A. M. T. & Tabrizi, S. J. \u201cOn chorea\u201d: 150 years of the beginning of hope. Mov. Disord. 37, 2194\u20132196 (2022).","journal-title":"Mov. Disord."},{"key":"906_CR3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E. et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"906_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.1312","volume":"50","author":"RL Margolis","year":"2001","unstructured":"Margolis, R. L. et al. A disorder similar to Huntington\u2019s disease is associated with a novel CAG repeat expansion. Ann. Neurol. 50, 373\u2013380 (2001).","journal-title":"Ann. Neurol."},{"key":"906_CR5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/WCO.0000000000000386","volume":"29","author":"RL Margolis","year":"2016","unstructured":"Margolis, R. L. & Rudnicki, D. D. Pathogenic insights from Huntington\u2019s disease-like 2 and other Huntington\u2019s disease genocopies. Curr. Opin. Neurol. 29, 743\u2013748 (2016).","journal-title":"Curr. Opin. Neurol."},{"key":"906_CR6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ajmg.b.32332","volume":"168","author":"A Krause","year":"2015","unstructured":"Krause, A. et al. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168, 573\u2013585 (2015).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"906_CR7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/mdc3.12742","volume":"6","author":"DG Anderson","year":"2019","unstructured":"Anderson, D. G. et al. Comparison of the Huntington\u2019s disease like 2 and Huntington\u2019s disease clinical phenotypes. Mov. Disord. Clin. Pract. 6, 302\u2013311 (2019).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"906_CR8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi, S. J. et al. Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 8, 791\u2013801 (2009).","journal-title":"Lancet Neurol."},{"key":"906_CR9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen, J. S. et al. Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study. J. Neurol. Neurosurg. Psychiatry 79, 874\u2013880 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"906_CR10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nbt.3648","volume":"34","author":"DM Ruderfer","year":"2016","unstructured":"Ruderfer, D. M. & Dudley, J. T. Deep phenotyping predicts Huntington\u2019s genotype. Nat. Biotechnol. 34, 823\u2013824 (2016).","journal-title":"Nat. Biotechnol."},{"key":"906_CR11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(11)70070-9","volume":"10","author":"DW Weir","year":"2011","unstructured":"Weir, D. W., Sturrock, A. & Leavitt, B. R. Development of biomarkers for Huntington\u2019s disease. Lancet Neurol. 10, 573\u2013590 (2011).","journal-title":"Lancet Neurol."},{"key":"906_CR12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi, S. J. et al. Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol. 21, 645\u2013658 (2022).","journal-title":"Lancet Neurol."},{"key":"906_CR13","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/mds.29228","volume":"37","author":"A Medina","year":"2022","unstructured":"Medina, A., Mahjoub, Y., Shaver, L. & Pringsheim, T. Prevalence and incidence of Huntington\u2019s disease: an updated systematic review and meta-analysis. Mov. Disord. 37, 2327\u20132335 (2022).","journal-title":"Mov. Disord."},{"key":"906_CR14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/mdc3.12312","volume":"3","author":"SA Schneider","year":"2016","unstructured":"Schneider, S. A. & Bird, T. Huntington\u2019s disease, Huntington\u2019s disease look-alikes, and benign hereditary chorea: what\u2019s new? Mov. Disord. Clin. Pract. 3, 342\u2013354 (2016).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"906_CR15","first-page":"852","volume":"54","author":"SE Andrew","year":"1994","unstructured":"Andrew, S. E. et al. Huntington disease without CAG expansion: phenocopies or errors in assignment? Am. J. Hum. Genet. 54, 852\u2013863 (1994).","journal-title":"Am. J. Hum. Genet."},{"key":"906_CR16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.21915","volume":"23","author":"EJ Wild","year":"2008","unstructured":"Wild, E. J. et al. Huntington\u2019s disease phenocopies are clinically and genetically heterogeneous. Mov. Disord. 23, 716\u2013720 (2008).","journal-title":"Mov. Disord."},{"key":"906_CR17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ncpneuro0606","volume":"3","author":"SA Schneider","year":"2007","unstructured":"Schneider, S. A., Walker, R. H. & Bhatia, K. P. The Huntington\u2019s disease-like syndromes: what to consider in patients with a negative Huntington\u2019s disease gene test. Nat. Clin. Pract. Neurol. 3, 517\u2013525 (2007).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"906_CR18","doi-asserted-by":"crossref","first-page":"817753","DOI":"10.3389\/fneur.2022.817753","volume":"13","author":"QTR Nguyen","year":"2022","unstructured":"Nguyen, Q. T. R. et al. Combining literature review with a ground truth approach for diagnosing Huntington\u2019s disease phenocopy. Front. Neurol. 13, 817753 (2022).","journal-title":"Front. Neurol."},{"key":"906_CR19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/WNL.0000000000000061","volume":"82","author":"DJ Hensman Moss","year":"2014","unstructured":"Hensman Moss, D. J. et al. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology 82, 292\u2013299 (2014).","journal-title":"Neurology"},{"key":"906_CR20","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1086\/324414","volume":"69","author":"RC Moore","year":"2001","unstructured":"Moore, R. C. et al. Huntington disease phenocopy is a familial prion disease. Am. J. Hum. Genet. 69, 1385\u20131388 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"906_CR21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1086\/302744","volume":"66","author":"M Kambouris","year":"2000","unstructured":"Kambouris, M., Bohlega, S., Al-Tahan, A. & Meyer, B. F. Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3. Am. J. Hum. Genet. 66, 445\u2013452 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"906_CR22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443738","volume":"46","author":"MD Rawlins","year":"2016","unstructured":"Rawlins, M. D. et al. The prevalence of Huntington\u2019s disease. Neuroepidemiology 46, 144\u2013153 (2016).","journal-title":"Neuroepidemiology"},{"key":"906_CR23","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ejhg.2013.2","volume":"21","author":"FK Baine","year":"2013","unstructured":"Baine, F. K. et al. Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes. Eur. J. Hum. Genet. 21, 1120\u20131127 (2013).","journal-title":"Eur. J. Hum. Genet."},{"key":"906_CR24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/mdc3.12474","volume":"4","author":"E Cubo","year":"2017","unstructured":"Cubo, E. et al. The burden of movement disorders in Cameroon: a rural and urban-based inpatient\/outpatient study. Mov. Disord. Clin. Pract. 4, 568\u2013573 (2017).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"906_CR25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000444020","volume":"46","author":"FK Baine","year":"2016","unstructured":"Baine, F. K., Krause, A. & Greenberg, L. J. The frequency of Huntington disease and Huntington disease-like 2 in the South African population. Neuroepidemiology 46, 198\u2013202 (2016).","journal-title":"Neuroepidemiology"},{"key":"906_CR26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajmg.b.32618","volume":"177","author":"C Kay","year":"2018","unstructured":"Kay, C. et al. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 177, 346\u2013357 (2018).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"906_CR27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng760","volume":"29","author":"SE Holmes","year":"2001","unstructured":"Holmes, S. E. et al. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat. Genet. 29, 377\u2013378 (2001).","journal-title":"Nat. Genet."},{"key":"906_CR28","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.20248","volume":"56","author":"RL Margolis","year":"2004","unstructured":"Margolis, R. L. et al. Huntington\u2019s disease-like 2 (HDL2) in North America and Japan. Ann. Neurol. 56, 670\u2013674 (2004).","journal-title":"Ann. Neurol."},{"key":"906_CR29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0000000000200830","volume":"99","author":"NM Robbins","year":"2022","unstructured":"Robbins, N. M. et al. Black patients matter in neurology: race, racism, and race-based neurodisparities. Neurology 99, 106\u2013114 (2022).","journal-title":"Neurology"},{"key":"906_CR30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2018.05.021","volume":"53","author":"RH Walker","year":"2018","unstructured":"Walker, R. H. et al. Huntington\u2019s disease-like disorders in Latin America and the Caribbean. Parkinsonism Relat. Disord. 53, 10\u201320 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"906_CR31","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/mds.22223","volume":"23","author":"GGR Rodrigues","year":"2008","unstructured":"Rodrigues, G. G. R. et al. Huntington\u2019s disease-like 2 in Brazil\u2013report of 4 patients. Mov. Disord. 23, 2244\u20132247 (2008).","journal-title":"Mov. Disord."},{"key":"906_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/jhg.2012.111","volume":"58","author":"I Paradisi","year":"2013","unstructured":"Paradisi, I., Ikonomu, V. & Arias, S. Huntington disease-like 2 Venezuela: frequency ethnic origin. J. Hum. Genet. 58, 3\u20136 (2013).","journal-title":"J. Hum. Genet."},{"key":"906_CR33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-0004.2008.00981.x","volume":"73","author":"C Santos","year":"2008","unstructured":"Santos, C. et al. Huntington disease-like 2: the first patient with apparent European ancestry. Clin. Genet. 73, 480\u2013485 (2008).","journal-title":"Clin. Genet."},{"key":"906_CR34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1073\/pnas.0126614100","volume":"100","author":"FC Parra","year":"2003","unstructured":"Parra, F. C. et al. Color and genomic ancestry in Brazilians. Proc. Natl Acad. Sci. USA 100, 177\u2013182 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"906_CR35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1590\/1678-4685-gmb-2018-0076","volume":"42","author":"AM de Souza","year":"2019","unstructured":"de Souza, A. M., Resende, S. S., de Sousa, T. N. & de Brito, C. F. A. A systematic scoping review of the genetic ancestry of the Brazilian population. Genet. Mol. Biol. 42, 495\u2013508 (2019).","journal-title":"Genet. Mol. Biol."},{"key":"906_CR36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-0004.2008.01055.x","volume":"75","author":"GGR Rodrigues","year":"2009","unstructured":"Rodrigues, G. G. R., Teive, H. A. G. & Tumas, V. Huntington\u2019s disease-like 2 and apparent ancestry. Clin. Genet. 75, 207 (2009).","journal-title":"Clin. Genet."},{"key":"906_CR37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JHD-160232","volume":"6","author":"DG Anderson","year":"2017","unstructured":"Anderson, D. G. et al. A systematic review of the Huntington disease-like 2 phenotype. J. Huntingt. Dis. 6, 37\u201346 (2017).","journal-title":"J. Huntingt. Dis."},{"key":"906_CR38","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/brain\/awg155","volume":"126","author":"G Stevanin","year":"2003","unstructured":"Stevanin, G. et al. Huntington\u2019s disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126, 1599\u20131603 (2003).","journal-title":"Brain"},{"key":"906_CR39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2016.2215","volume":"73","author":"L Mariani","year":"2016","unstructured":"Mariani, L. et al. Expanding the spectrum of genes involved in Huntington disease using a combined clinical and genetic approach. JAMA Neurol. 73, 1105\u20131114 (2016).","journal-title":"JAMA Neurol."},{"key":"906_CR40","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6308","volume":"10","author":"F Ruscitti","year":"2022","unstructured":"Ruscitti, F. et al. A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era. Clin. Case Rep. 10, e6308 (2022).","journal-title":"Clin. Case Rep."},{"key":"906_CR41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jns.2018.04.031","volume":"390","author":"FK Baine","year":"2018","unstructured":"Baine, F. K., Peerbhai, N. & Krause, A. A study of Huntington disease-like syndromes in black South African patients reveals a single SCA2 mutation and a unique distribution of normal alleles across five repeat loci. J. Neurol. Sci. 390, 200\u2013204 (2018).","journal-title":"J. Neurol. Sci."},{"key":"906_CR42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jocn.2017.10.025","volume":"47","author":"C Ocampo","year":"2018","unstructured":"Ocampo, C., Daimari, R. & Oyekunle, A. A. Huntington\u2019s disease-like 2 with an expansion mutation of the Junctophilin-3 gene; first reported case from Botswana. J. Clin. Neurosci. 47, 126\u2013127 (2018).","journal-title":"J. Clin. Neurosci."},{"key":"906_CR43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ajhg.2020.06.012","volume":"107","author":"SJ Micheletti","year":"2020","unstructured":"Micheletti, S. J. et al. Genetic consequences of the transatlantic slave trade in the Americas. Am. J. Hum. Genet. 107, 265\u2013277 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"906_CR44","doi-asserted-by":"publisher","unstructured":"Muthinja, M. J. et al. An exploration of the genetics of the mutant Huntingtin (mHtt) gene in a cohort of patients with chorea from different tribes in 6 sub-Saharan African countries. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2022.07.13.22272435 (2022).","DOI":"10.1101\/2022.07.13.22272435"},{"key":"906_CR45","first-page":"331","volume":"21","author":"FN Chukwuneke","year":"2012","unstructured":"Chukwuneke, F. N., Ezeonu, C. T., Onyire, B. N. & Ezeonu, P. O. Culture and biomedical care in Africa: the influence of culture on biomedical care in a traditional African society, Nigeria, West Africa. Niger. J. Med. 21, 331\u2013333 (2012).","journal-title":"Niger. J. Med."},{"key":"906_CR46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10745-009-9242-5","volume":"37","author":"SM Glover","year":"2009","unstructured":"Glover, S. M. Mark Nichter: global health: why cultural perceptions, social representations, and biopolitics matter. Hum. Ecol. 37, 669\u2013670 (2009).","journal-title":"Hum. Ecol."},{"key":"906_CR47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ana.22598","volume":"71","author":"AI Seixas","year":"2012","unstructured":"Seixas, A. I. et al. Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis. Ann. Neurol. 71, 245\u2013257 (2012).","journal-title":"Ann. Neurol."},{"key":"906_CR48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jmg.19.2.94","volume":"19","author":"MR Hayden","year":"1982","unstructured":"Hayden, M. R., MacGregor, J. M., Saffer, D. S. & Beighton, P. H. The high frequency of juvenile Huntington\u2019s chorea in South Africa. J. Med. Genet. 19, 94\u201397 (1982).","journal-title":"J. Med. Genet."},{"key":"906_CR49","doi-asserted-by":"crossref","first-page":"e4f8606b742ef3","DOI":"10.1371\/4f8606b742ef3","volume":"4","author":"O Quarrell","year":"2012","unstructured":"Quarrell, O., O\u2019Donovan, K. L., Bandmann, O. & Strong, M. the prevalence of juvenile Huntington\u2019s disease: a review of the literature and meta-analysis. PLoS Curr. 4, e4f8606b742ef3 (2012).","journal-title":"PLoS Curr."},{"key":"906_CR50","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/mds.21672","volume":"22","author":"S Bardien","year":"2007","unstructured":"Bardien, S. et al. A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features. Mov. Disord. 22, 2083\u20132089 (2007).","journal-title":"Mov. Disord."},{"key":"906_CR51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajhg.2009.02.003","volume":"84","author":"SC Warby","year":"2009","unstructured":"Warby, S. C. et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am. J. Hum. Genet. 84, 351\u2013366 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"906_CR52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrg1689","volume":"6","author":"CE Pearson","year":"2005","unstructured":"Pearson, C. E., Nichol Edamura, K. & Cleary, J. D. Repeat instability: mechanisms of dynamic mutations. Nat. Rev. Genet. 6, 729\u2013742 (2005).","journal-title":"Nat. Rev. Genet."},{"key":"906_CR53","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrg2828","volume":"11","author":"CT McMurray","year":"2010","unstructured":"McMurray, C. T. Mechanisms of trinucleotide repeat instability during human development. Nat. Rev. Genet. 11, 786\u2013799 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"906_CR54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jmg.31.1.37","volume":"31","author":"A Goldman","year":"1994","unstructured":"Goldman, A., Ramsay, M. & Jenkins, T. Absence of myotonic dystrophy in southern African Negroids is associated with a significantly lower number of CTG trinucleotide repeats. J. Med. Genet. 31, 37\u201340 (1994).","journal-title":"J. Med. Genet."},{"key":"906_CR55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s004399900091","volume":"105","author":"M Gennarelli","year":"1999","unstructured":"Gennarelli, M. et al. CTG repeats distribution and Alu insertion polymorphism at myotonic dystrophy (DM) gene in Amhara and Oromo populations of Ethiopia. Hum. Genet. 105, 165\u2013167 (1999).","journal-title":"Hum. Genet."},{"key":"906_CR56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/(SICI)1096-8628(19960712)64:1<216::AID-AJMG39>3.0.CO;2-O","volume":"64","author":"P Chiurazzi","year":"1996","unstructured":"Chiurazzi, P. et al. Extended gene diversity at the FMR1 locus and neighbouring CA repeats in a sub-Saharan population. Am. J. Med. Genet. 64, 216\u2013219 (1996).","journal-title":"Am. J. Med. Genet."},{"key":"906_CR57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/(SICI)1096-8628(19971231)73:4<463::AID-AJMG16>3.0.CO;2-P","volume":"73","author":"RJ Ritchie","year":"1997","unstructured":"Ritchie, R. J., Chakrabarti, L., Knight, S. J., Harding, R. M. & Davies, K. E. Population genetics of the FRAXE and FRAXF GCC repeats, and a novel CGG repeat, in Xq28. Am. J. Med. Genet. 73, 463\u2013469 (1997).","journal-title":"Am. J. Med. Genet."},{"key":"906_CR58","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1469-1809.2010.00582.x","volume":"74","author":"EK Peprah","year":"2010","unstructured":"Peprah, E. K., Allen, E. G., Williams, S. M., Woodard, L. M. & Sherman, S. L. Genetic diversity of the fragile X syndrome gene (FMR1) in a large sub-Saharan West African population. Ann. Hum. Genet. 74, 316\u2013325 (2010).","journal-title":"Ann. Hum. Genet."},{"key":"906_CR59","unstructured":"Levesley, J. Investigating allele sequence diversity at the Huntington disease loci HTT and JPH3 in African ancestry individuals. The University of the Witwatersrand: Electronic Theses and Dissertations https:\/\/wiredspace.wits.ac.za\/items\/25004bb1-ea69-4035-bec5-1134d077c768. (2021)."},{"key":"906_CR60","doi-asserted-by":"publisher","unstructured":"Iba\u00f1ez, K. et al. Population frequency of repeat expansions indicates increased disease prevalence estimates across different populations. Preprint at: medRxiv https:\/\/doi.org\/10.1101\/2023.07.03.23292162 (2023).","DOI":"10.1101\/2023.07.03.23292162"},{"key":"906_CR61","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/hmg\/3.12.2103","volume":"3","author":"F Squitieri","year":"1994","unstructured":"Squitieri, F. et al. DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum. Mol. Genet. 3, 2103\u20132114 (1994).","journal-title":"Hum. Mol. Genet."},{"key":"906_CR62","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ebiom.2019.09.020","volume":"48","author":"M Ciosi","year":"2019","unstructured":"Ciosi, M. et al. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes. EBioMedicine 48, 568\u2013580 (2019).","journal-title":"EBioMedicine"},{"key":"906_CR63","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","volume":"178","author":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium.","year":"2019","unstructured":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium. CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset. Cell 178, 887\u2013900.e14 (2019).","journal-title":"Cell"},{"key":"906_CR64","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ajhg.2019.04.007","volume":"104","author":"GEB Wright","year":"2019","unstructured":"Wright, G. E. B. et al. Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease. Am. J. Hum. Genet. 104, 1116\u20131126 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"906_CR65","first-page":"100130","volume":"3","author":"J Dawson","year":"2022","unstructured":"Dawson, J. et al. A probable cis-acting genetic modifier of Huntington disease frequent in individuals with African ancestry. HGG Adv. 3, 100130 (2022).","journal-title":"HGG Adv."},{"key":"906_CR66","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s13311-019-00768-7","volume":"16","author":"T Maiuri","year":"2019","unstructured":"Maiuri, T. et al. DNA damage repair in Huntington\u2019s disease and other neurodegenerative diseases. Neurotherapeutics 16, 948\u2013956 (2019).","journal-title":"Neurotherapeutics"},{"key":"906_CR67","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium.","year":"2015","unstructured":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium. Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell 162, 516\u2013526 (2015).","journal-title":"Cell"},{"key":"906_CR68","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ajhg.2022.03.004","volume":"109","author":"J Lee","year":"2022","unstructured":"Lee, J. et al. Genetic modifiers of Huntington disease differentially influence motor and cognitive domains. Am. J. Hum. Genet. 109, 885\u2013899 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"906_CR69","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/mds.21417","volume":"22","author":"PE Greenstein","year":"2007","unstructured":"Greenstein, P. E., Vonsattel, J. G., Margolis, R. L. & Joseph, J. T. Huntington\u2019s disease like-2 neuropathology. Mov. Disord. 22, 1416\u20131423 (2007).","journal-title":"Mov. Disord."},{"key":"906_CR70","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1212\/WNL.58.7.1031","volume":"58","author":"RH Walker","year":"2002","unstructured":"Walker, R. H. et al. Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions. Neurology 58, 1031\u20131037 (2002).","journal-title":"Neurology"},{"key":"906_CR71","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1212\/01.WNL.0000085866.68470.6D","volume":"61","author":"RH Walker","year":"2003","unstructured":"Walker, R. H. et al. Huntington\u2019s disease-like 2 can present as chorea-acanthocytosis. Neurology 61, 1002\u20131004 (2003).","journal-title":"Neurology"},{"key":"906_CR72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/342260","volume":"71","author":"A Krause","year":"2002","unstructured":"Krause, A., Temlett, J. & Van der Meyden, K. CAG\/CTG repeat expansions at the HDL2 locus are a common cause of Huntington disease in Black South Africans (Abstr.). Am. J. Hum. Genet. 71, 528 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"906_CR73","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/NEN.0b013e31816b4aee","volume":"67","author":"DD Rudnicki","year":"2008","unstructured":"Rudnicki, D. D., Pletnikova, O., Vonsattel, J. G., Ross, C. A. & Margolis, R. L. A comparison of Huntington disease and Huntington disease-like 2 neuropathology. J. Neuropathol. Exp. Neurol. 67, 366\u2013374 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"906_CR74","doi-asserted-by":"crossref","first-page":"101666","DOI":"10.1016\/j.nicl.2019.101666","volume":"21","author":"DG Anderson","year":"2019","unstructured":"Anderson, D. G. et al. Emerging differences between Huntington\u2019s disease-like 2 and Huntington\u2019s disease: a comparison using MRI brain volumetry. Neuroimage Clin. 21, 101666 (2019).","journal-title":"Neuroimage Clin."},{"key":"906_CR75","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1212\/WNL.58.6.965","volume":"58","author":"G Stevanin","year":"2002","unstructured":"Stevanin, G. et al. CAG\/CTG repeat expansions at the Huntington\u2019s disease-like 2 locus are rare in Huntington\u2019s disease patients. Neurology 58, 965\u2013967 (2002).","journal-title":"Neurology"},{"key":"906_CR76","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10048-012-0318-9","volume":"13","author":"SA Schneider","year":"2012","unstructured":"Schneider, S. A., Marshall, K. E., Xiao, J. & LeDoux, M. S. JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family. Neurogenetics 13, 133\u2013140 (2012).","journal-title":"Neurogenetics"},{"key":"906_CR77","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/mds.10587","volume":"18","author":"RH Walker","year":"2003","unstructured":"Walker, R. H., Jankovic, J., O\u2019Hearn, E. & Margolis, R. L. Phenotypic features of Huntington\u2019s disease-like 2. Mov. Disord. 18, 1527\u20131530 (2003).","journal-title":"Mov. Disord."},{"key":"906_CR78","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.parkreldis.2020.01.008","volume":"71","author":"E Mulroy","year":"2020","unstructured":"Mulroy, E. et al. Huntington disease like 2 (HDL-2) with parkinsonism and abnormal DAT-SPECT \u2014 a novel observation. Parkinsonism Relat. Disord. 71, 46\u201348 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"906_CR79","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"[No authors listed]","year":"1996","unstructured":"[No authors listed] Unified Huntington\u2019s disease rating scale: reliability and consistency. Huntington Study Group.Mov. Disord. 11, 136\u2013142 (1996).","journal-title":"Mov. Disord."},{"key":"906_CR80","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1016\/S0042-6989(96)00169-1","volume":"37","author":"AG Lasker","year":"1997","unstructured":"Lasker, A. G. & Zee, D. S. Ocular motor abnormalities in Huntington\u2019s disease. Vis. Res. 37, 3639\u20133645 (1997).","journal-title":"Vis. Res."},{"key":"906_CR81","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mds.24024","volume":"27","author":"A Rosenblatt","year":"2012","unstructured":"Rosenblatt, A. et al. Age, CAG repeat length, and clinical progression in Huntington\u2019s disease. Mov. Disord. 27, 272\u2013276 (2012).","journal-title":"Mov. Disord."},{"key":"906_CR82","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ana.21081","volume":"61","author":"DD Rudnicki","year":"2007","unstructured":"Rudnicki, D. D. et al. Huntington\u2019s disease-like 2 is associated with CUG repeat-containing RNA foci. Ann. Neurol. 61, 272\u2013282 (2007).","journal-title":"Ann. Neurol."},{"key":"906_CR83","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JHD-200422","volume":"9","author":"A Ferreira-Correia","year":"2020","unstructured":"Ferreira-Correia, A., Krause, A. & Anderson, D. G. The neuropsychiatry of Huntington disease-like 2: a comparison with Huntington\u2019s disease. J. Huntingt. Dis. 9, 325\u2013334 (2020).","journal-title":"J. Huntingt. Dis."},{"key":"906_CR84","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1566-2772(03)00061-6","volume":"3","author":"RL Margolis","year":"2003","unstructured":"Margolis, R. L. & Holmes, S. E. Huntington\u2019s disease-like 2: a clinical, pathological, and molecular comparison to Huntington\u2019s disease. Clin. Neurosci. Res. 3, 187\u2013196 (2003).","journal-title":"Clin. Neurosci. Res."},{"key":"906_CR85","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff, K. et al. Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the predict-HD study. Biol. Psychiatry 62, 1341\u20131346 (2007).","journal-title":"Biol. Psychiatry"},{"key":"906_CR86","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1176\/appi.neuropsych.11120358","volume":"24","author":"CA Fischer","year":"2012","unstructured":"Fischer, C. A., Licht, E. A. & Mendez, M. F. The neuropsychiatric manifestations of Huntington\u2019s disease-like 2. J. Neuropsychiatry Clin. Neurosci. 24, 489\u2013492 (2012).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"906_CR87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/cge.12283","volume":"86","author":"RM Castilhos","year":"2014","unstructured":"Castilhos, R. M. et al. Huntington disease and Huntington disease-like in a case series from Brazil. Clin. Genet. 86, 373\u2013377 (2014).","journal-title":"Clin. Genet."},{"key":"906_CR88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/jhg.2012.111","volume":"58","author":"I Paradisi","year":"2013","unstructured":"Paradisi, I., Ikonomu, V. & Arias, S. Huntington disease-like 2 (HDL2) in Venezuela: frequency and ethnic origin. J. Hum. Genet. 58, 3\u20136 (2013).","journal-title":"J. Hum. Genet."},{"key":"906_CR89","doi-asserted-by":"crossref","first-page":"107238","DOI":"10.1016\/j.neuropsychologia.2019.107238","volume":"136","author":"A Ferreira-Correia","year":"2020","unstructured":"Ferreira-Correia, A., Anderson, D. G., Cockcroft, K. & Krause, A. The neuropsychological deficits and dissociations in Huntington disease-like 2: a series of case-control studies. Neuropsychologia 136, 107238 (2020).","journal-title":"Neuropsychologia"},{"key":"906_CR90","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/23279095.2020.1734810","volume":"29","author":"A Ferreira-Correia","year":"2022","unstructured":"Ferreira-Correia, A., Anderson, D. G., Cockcroft, K. & Krause, A. A comparison between the neurocognitive profile of Huntington disease-like 2 and Huntington disease: exploring the presence of double dissociations. Appl. Neuropsychol. Adult 29, 223\u2013233 (2022).","journal-title":"Appl. Neuropsychol. Adult"},{"key":"906_CR91","doi-asserted-by":"publisher","unstructured":"Ferreira-Correia, A. & Cockcroft, K. Controlling for inequality in neuropsychological assessment: using Crawford and Howell\u2019s (1998) single-case methodology with norms from demographically homogeneous groups of South Africans. S. Afr. J. Psychol.53, https:\/\/doi.org\/10.1177\/0081246322115100 (2023).","DOI":"10.1177\/0081246322115100"},{"key":"906_CR92","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JHD-150171","volume":"4","author":"A Roussakis","year":"2015","unstructured":"Roussakis, A. & Piccini, P. PET imaging in Huntington\u2019s disease. J. Huntingt. Dis. 4, 287\u2013296 (2015).","journal-title":"J. Huntingt. Dis."},{"key":"906_CR93","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.clineuro.2010.07.014","volume":"112","author":"J Gamez","year":"2010","unstructured":"Gamez, J. et al. Does reduced [123I]-FP-CIT binding in Huntington\u2019s disease suggest pre-synaptic dopaminergic involvement? Clin. Neurol. Neurosurg. 112, 870\u2013875 (2010).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"906_CR94","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/378403a0","volume":"378","author":"Y Trottier","year":"1995","unstructured":"Trottier, Y. et al. Polyglutamine expansion as a pathological epitope in Huntington\u2019s disease and four dominant cerebellar ataxias. Nature 378, 403\u2013406 (1995).","journal-title":"Nature"},{"key":"906_CR95","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.wco.0000173464.01888.e9","volume":"18","author":"A Danek","year":"2005","unstructured":"Danek, A. & Walker, R. H. Neuroacanthocytosis. Curr. Opin. Neurol. 18, 386\u2013392 (2005).","journal-title":"Curr. Opin. Neurol."},{"key":"906_CR96","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5334\/tohm.349","volume":"7","author":"DG Anderson","year":"2017","unstructured":"Anderson, D. G. et al. Absence of acanthocytosis in Huntington\u2019s disease-like 2: a prospective comparison with Huntington\u2019s disease. Tremor Other Hyperkinet Mov. 7, 512 (2017).","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"906_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5334\/tohm.583","volume":"11","author":"RH Walker","year":"2021","unstructured":"Walker, R. H. & Danek, A. \u201cNeuroacanthocytosis\u201d \u2014 overdue for a taxonomic update. Tremor Other Hyperkinet Mov. 11, 1 (2021).","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"906_CR98","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi, S. J., Flower, M. D., Ross, C. A. & Wild, E. J. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat. Rev. Neurol. 16, 529\u2013546 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"906_CR99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JHD-200438","volume":"10","author":"RR Iyer","year":"2021","unstructured":"Iyer, R. R. & Pluciennik, A. DNA mismatch repair and its role in Huntington\u2019s disease. J. Huntingt. Dis. 10, 75\u201394 (2021).","journal-title":"J. Huntingt. Dis."},{"key":"906_CR100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bpa.12427","volume":"26","author":"E Marti","year":"2016","unstructured":"Marti, E. RNA toxicity induced by expanded CAG repeats in Huntington\u2019s disease. Brain Pathol. 26, 779\u2013786 (2016).","journal-title":"Brain Pathol."},{"key":"906_CR101","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.neuron.2015.10.038","volume":"88","author":"M Banez-Coronel","year":"2015","unstructured":"Banez-Coronel, M. et al. RAN translation in Huntington disease. Neuron 88, 667\u2013677 (2015).","journal-title":"Neuron"},{"key":"906_CR102","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam, K. et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc. Natl Acad. Sci. USA 110, 2366\u20132370 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"906_CR103","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1093\/hmg\/ddr263","volume":"20","author":"DW Chung","year":"2011","unstructured":"Chung, D. W., Rudnicki, D. D., Yu, L. & Margolis, R. L. A natural antisense transcript at the Huntington\u2019s disease repeat locus regulates HTT expression. Hum. Mol. Genet. 20, 3467\u20133477 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"906_CR104","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou, F. & Humbert, S. The biology of huntingtin. Neuron 89, 910\u2013926 (2016).","journal-title":"Neuron"},{"key":"906_CR105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1152\/physrev.00024.2021","volume":"102","author":"SE Lehnart","year":"2022","unstructured":"Lehnart, S. E. & Wehrens, X. H. T. The role of junctophilin proteins in cellular function. Physiol. Rev. 102, 1211\u20131261 (2022).","journal-title":"Physiol. Rev."},{"key":"906_CR106","doi-asserted-by":"crossref","first-page":"iyab063","DOI":"10.1093\/genetics\/iyab063","volume":"218","author":"CA Piggott","year":"2021","unstructured":"Piggott, C. A. et al. Caenorhabditis elegans junctophilin has tissue-specific functions and regulates neurotransmission with extended-synaptotagmin. Genetics 218, iyab063 (2021).","journal-title":"Genetics"},{"key":"906_CR107","first-page":"11","volume":"6","author":"H Takeshima","year":"2000","unstructured":"Takeshima, H., Komazaki, S., Nishi, M., Iino, M. & Kangawa, K. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell 6, 11\u201322 (2000).","journal-title":"Mol. Cell"},{"key":"906_CR108","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2014.02.004","volume":"20","author":"AP Landstrom","year":"2014","unstructured":"Landstrom, A. P., Beavers, D. L. & Wehrens, X. H. T. The junctophilin family of proteins: from bench to bedside. Trends Mol. Med. 20, 353\u2013362 (2014).","journal-title":"Trends Mol. Med."},{"key":"906_CR109","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12311-008-0040-1","volume":"7","author":"S Kakizawa","year":"2008","unstructured":"Kakizawa, S., Moriguchi, S., Ikeda, A., Iino, M. & Takeshima, H. Functional crosstalk between cell-surface and intracellular channels mediated by junctophilins essential for neuronal functions. Cerebellum 7, 385\u2013391 (2008).","journal-title":"Cerebellum"},{"key":"906_CR110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ceca.2015.01.007","volume":"58","author":"H Takeshima","year":"2015","unstructured":"Takeshima, H., Hoshijima, M. & Song, L. Ca2+ microdomains organized by junctophilins. Cell Calcium 58, 349\u2013356 (2015).","journal-title":"Cell Calcium"},{"key":"906_CR111","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.celrep.2019.07.075","volume":"28","author":"G Sahu","year":"2019","unstructured":"Sahu, G. et al. Junctophilin proteins tether a Cav1-RyR2-KCa3.1 tripartite complex to regulate neuronal excitability. Cell. Rep. 28, 2427\u20132442.e6 (2019).","journal-title":"Cell. Rep."},{"key":"906_CR112","doi-asserted-by":"crossref","first-page":"eaan3303","DOI":"10.1126\/science.aan3303","volume":"362","author":"A Guo","year":"2018","unstructured":"Guo, A. et al. E-C coupling structural protein junctophilin-2 encodes a stress-adaptive transcription regulator. Science 362, eaan3303 (2018).","journal-title":"Science"},{"key":"906_CR113","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00395-020-0807-1","volume":"115","author":"SK Lahiri","year":"2020","unstructured":"Lahiri, S. K. et al. Nuclear localization of a novel calpain-2 mediated junctophilin-2 C-terminal cleavage peptide promotes cardiomyocyte remodeling. Basic Res. Cardiol. 115, 49 (2020).","journal-title":"Basic Res. Cardiol."},{"key":"906_CR114","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1006\/bbrc.2002.6649","volume":"292","author":"M Nishi","year":"2002","unstructured":"Nishi, M. et al. Motor discoordination in mutant mice lacking junctophilin type 3. Biochem. Biophys. Res. Commun. 292, 318\u2013324 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"906_CR115","doi-asserted-by":"crossref","first-page":"dmm029082","DOI":"10.1242\/dmm.029082","volume":"11","author":"E Calpena","year":"2018","unstructured":"Calpena, E. et al. The Drosophila junctophilin gene is functionally equivalent to its four mammalian counterparts and is a modifier of a Huntingtin poly-Q expansion and the Notch pathway. Dis. Model. Mech. 11, dmm029082 (2018).","journal-title":"Dis. Model. Mech."},{"key":"906_CR116","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ajhg.2009.03.010","volume":"84","author":"HV Firth","year":"2009","unstructured":"Firth, H. V. et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources. Am. J. Hum. Genet. 84, 524\u2013533 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"906_CR117","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41431-021-00866-1","volume":"29","author":"T Bourinaris","year":"2021","unstructured":"Bourinaris, T. et al. Allelic and phenotypic heterogeneity in Junctophillin-3 related neurodevelopmental and movement disorders. Eur. J. Hum. Genet. 29, 1027\u20131031 (2021).","journal-title":"Eur. J. Hum. Genet."},{"key":"906_CR118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/mds.29250","volume":"38","author":"D Steel","year":"2023","unstructured":"Steel, D. et al. Both heterozygous and homozygous loss-of-function JPH3 variants are associated with a paroxysmal movement disorder. Mov. Disord. 38, 155\u2013157 (2023).","journal-title":"Mov. Disord."},{"key":"906_CR119","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/hmg\/10.22.2515","volume":"10","author":"W Auerbach","year":"2001","unstructured":"Auerbach, W. et al. The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. Hum. Mol. Genet. 10, 2515\u20132523 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"906_CR120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007765","volume":"15","author":"V Murthy","year":"2019","unstructured":"Murthy, V. et al. Hypomorphic mutation of the mouse Huntington\u2019s disease gene orthologue. PLoS Genet. 15, e1007765 (2019).","journal-title":"PLoS Genet."},{"key":"906_CR121","doi-asserted-by":"crossref","first-page":"10491","DOI":"10.3390\/ijms231810491","volume":"23","author":"L Timchenko","year":"2022","unstructured":"Timchenko, L. Development of therapeutic approaches for myotonic dystrophies type 1 and type 2. Int. J. Mol. Sci. 23, 10491 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"906_CR122","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuron.2011.03.021","volume":"70","author":"B Wilburn","year":"2011","unstructured":"Wilburn, B. et al. An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington\u2019s disease-like 2 mice. Neuron 70, 427\u2013440 (2011).","journal-title":"Neuron"},{"key":"906_CR123","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FCJ Nucifora","year":"2001","unstructured":"Nucifora, F. C. J. et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291, 2423\u20132428 (2001).","journal-title":"Science"},{"key":"906_CR124","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/S0004-282X2011000400002","volume":"69","author":"GR Rodrigues","year":"2011","unstructured":"Rodrigues, G. R. et al. Clinical and genetic analysis of 29 Brazilian patients with Huntington\u2019s disease-like phenotype. Arq. Neuropsiquiatr. 69, 419\u2013423 (2011).","journal-title":"Arq. Neuropsiquiatr."},{"key":"906_CR125","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1007\/s10072-021-05527-1","volume":"42","author":"R Bonomo","year":"2021","unstructured":"Bonomo, R. et al. Deep brain stimulation in Huntington\u2019s disease: a literature review. Neurol. Sci. 42, 4447\u20134457 (2021).","journal-title":"Neurol. Sci."},{"key":"906_CR126","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3389\/fneur.2020.00547","volume":"11","author":"H Yu","year":"2020","unstructured":"Yu, H., Takahashi, K., Bloom, L., Quaynor, S. D. & Xie, T. Effect of deep brain stimulation on swallowing function: a systematic review. Front. Neurol. 11, 547 (2020).","journal-title":"Front. Neurol."},{"key":"906_CR127","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2018.09.022","volume":"396","author":"CM Testa","year":"2019","unstructured":"Testa, C. M. & Jankovic, J. Huntington disease: a quarter century of progress since the gene discovery. J. Neurol. Sci. 396, 52\u201368 (2019).","journal-title":"J. Neurol. Sci."},{"key":"906_CR128","doi-asserted-by":"crossref","first-page":"16933","DOI":"10.1002\/jcp.28405","volume":"234","author":"J Jiang","year":"2019","unstructured":"Jiang, J., Tang, M., Huang, Z. & Chen, L. Junctophilins emerge as novel therapeutic targets. J. Cell. Physiol. 234, 16933\u201316943 (2019).","journal-title":"J. Cell. Physiol."},{"key":"906_CR129","doi-asserted-by":"crossref","first-page":"667420","DOI":"10.3389\/fneur.2021.667420","volume":"12","author":"S Sathe","year":"2021","unstructured":"Sathe, S. et al. Enroll-HD: an integrated clinical research platform and worldwide observational study for Huntington\u2019s disease. Front. Neurol. 12, 667420 (2021).","journal-title":"Front. Neurol."},{"key":"906_CR130","first-page":"200","volume":"98","author":"DS Magazi","year":"2008","unstructured":"Magazi, D. S. et al. Huntington\u2019s disease: genetic heterogeneity in black African patients. S. Afr. Med. J. 98, 200\u2013203 (2008).","journal-title":"S. Afr. Med. J."},{"key":"906_CR131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2016.11.050","volume":"373","author":"LFR Vasconcellos","year":"2017","unstructured":"Vasconcellos, L. F. R. et al. Huntington\u2019s Disease like 2 presenting with isolated Parkinsonism. J. Neurol. Sci. 373, 105\u2013106 (2017).","journal-title":"J. Neurol. Sci."},{"key":"906_CR132","first-page":"S27","volume":"22","author":"HAG Teive","year":"2007","unstructured":"Teive, H. A. G. et al. Huntington\u2019s disease-like 2: the first case report in Latin America in a patient without African ethnic origin. Mov. Disord. 22, S27 (2007).","journal-title":"Mov. Disord."},{"key":"906_CR133","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/ajmg.a.36569","volume":"164A","author":"AH Seeley","year":"2014","unstructured":"Seeley, A. H. et al. Macrocerebellum, epilepsy, intellectual disability, and gut malrotation in a child with a 16q24.1-q24.2 contiguous gene deletion. Am. J. Med. Genet. A 164A, 2062\u20132068 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"906_CR134","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64249","volume":"10","author":"S Perni","year":"2021","unstructured":"Perni, S. & Beam, K. Neuronal junctophilins recruit specific CaV and RyR isoforms to ER-PM junctions and functionally alter CaV2.1 and CaV2.2. eLife 10, e64249 (2021).","journal-title":"eLife"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00906-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00906-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00906-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T09:44:30Z","timestamp":1730886270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00906-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1038\/s41582-023-00906-y","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"9 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}